The Biden-Harris administration yesterday sent Congress its first-year drug policy priorities, as required by each new administration. 

They call for expanding access to evidence-based treatment; advancing racial equity in drug policy; enhancing evidence-based efforts to reduce harm; supporting evidence-based efforts to prevent youth substance use; reducing the supply of illicit substances; removing barriers to employment for people in recovery and expanding the addiction workforce; and expanding access to recovery support services.
 

Related News Articles

Headline
The 2025 AHA Annual Membership Meeting began today with Joanne Conroy, M.D., president and CEO of Dartmouth Health and 2024 AHA board chair, discussing the…
Headline
Rep. Nathaniel Moran, R-Texas, and Rep. Brad Schneider, D-Ill., both members of the House Ways and Means Committee, spoke to the AHA Annual Membership Meeting…
Headline
Rep. Mariannette Miller-Meeks, R-Iowa, participated in a fireside chat during the afternoon plenary session today at the 2025 AHA Annual Membership meeting. As…
Headline
Stacey Hughes, AHA's executive vice president for government relations and public policy, discussed key issues being considered on Capitol Hill that would…
Headline
John Ashbrook, founding partner, Cavalry LLC, and co-host of the Ruthless Podcast, yesterday moderated a panel discussion between Leigh Ann Caldwell, chief…
Headline
President Trump today released his discretionary spending budget blueprint for fiscal year 2026. The “skinny budget” request, which includes top line…